Konte, Bettina http://orcid.org/0000-0001-5287-308X
Walters, James T. R.
Rujescu, Dan
Legge, Sophie E. http://orcid.org/0000-0001-6617-0289
Pardiñas, Antonio F. http://orcid.org/0000-0001-6845-7590
Cohen, Dan
Pirmohamed, Munir
Tiihonen, Jari http://orcid.org/0000-0002-0400-6798
Hartmann, Annette M.
Bogers, Jan P. http://orcid.org/0000-0001-7273-0027
van der Weide, Jan
van der Weide, Karen
Putkonen, Anu
Repo-Tiihonen, Eila
Hallikainen, Tero
Silva, Ed http://orcid.org/0000-0002-7254-6307
Ingimarsson, Oddur
Sigurdsson, Engilbert http://orcid.org/0000-0001-9404-7982
Kennedy, James L. http://orcid.org/0000-0002-8733-3806
Sullivan, Patrick F. http://orcid.org/0000-0002-6619-873X
Rietschel, Marcella http://orcid.org/0000-0002-5236-6149
Breen, Gerome
Stefansson, Hreinn http://orcid.org/0000-0002-9331-6666
Stefansson, Kari
Collier, David A. http://orcid.org/0000-0003-4087-1559
O’Donovan, Michael C. http://orcid.org/0000-0001-7073-2379
Giegling, Ina
Funding for this research was provided by:
EC | EC Seventh Framework Programm | FP7 Health (279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227, 279227)
EC | EC Seventh Framework Programm | FP7 Health
JTRW and MCO acknowledge support by a collaborative research grant from Takeda (Takeda played no part in the conception, design, implementation, or interpretation of this study).
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
MRC Centre for Drug Safety Science
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
EC | EC Seventh Framework Programm | FP7 Health
Article History
Received: 14 July 2020
Revised: 21 February 2021
Accepted: 11 March 2021
First Online: 12 April 2021
Conflict of interest
: D.A.C. is a full-time employee and stockholder of Eli Lilly and Company.